Activation of Protein Kinase A Improves Vascular Endothelial Dysfunction

REFERENCES

• Barman S. A., Zhu S., Han G., White R. E. cAMP activates BKCa channels in pulmonary arterial smooth muscle via cGMP-dependent protein kinase. American Journal of Physiology 2003; 284: 1004–1011, [CSA]
   Google Scholar
• Birukova A. A., Smurova K., Birukov K. G., Kaibuchi K., Garcia J. G., Verin A. D. Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvascular Research 2004; 67: 64–77, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Burgering B. M. T., Coffer P. J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995; 376: 599–602, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Calera M. R., Martinez C., Liu H., Jack A. K. E., Birnbaum M. J., Pilch P. F. Insulin increases the association of Akt-2 with Glut4-containing vesicles. Journal of Biological Chemistry 1998; 273: 7201–7204, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987; 162: 156–159, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• De Vriese A. S., Verbeuren T. J., van de Voorde J., Lameire N. H., Vanhoutte P. M. Endothelial dysfunction in diabetes. British Journal of Pharmacol 2000; 130: 963–974, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dimitrova K. R., DeGroot K. W., Pacquing A. M., Suyderhoud J. P., Pirovic E. A., Munro T. J., Wieneke J. A., Myers A. K., Kim Y. D. Estradiol prevents homocysteine-induced endothelial injury in male rats. Cardiovascular Research 2002; 53: 589–596, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Filippa N., Sable C. L., Filloux C., Hemmings B., van Obberghen E. Mechanism of protein pinase B activation by cyclic AMP-dependent protein kinase. Molecular and Cellular Biology 1999; 19: 4989–5000, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fonesca V., Keebler M., Dicker-Brown A., DeSouza C., Poirier L. A., Murthy S. N., McNamara D. B. The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in zucker rats. Metabolism 2002; 61: 783–786, [CROSSREF], [CSA]
   Google Scholar
• Fulton D., Gratton J. P., Sessa W. C. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. Journal of Pharmacology and Experimental Therapeutics 2001; 299: 818–824, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Goncalves d e, Moraes V. L., Singer M., Vargaftig B. B., Chignard M. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung. British Journal of Pharmacology 1998; 123: 631–636, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hayden M. R., Tyagi S. C. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleotropic effects of folate supplementation. Nutrition Journal 2004; 3: 4–27, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Heijnen H. F.G., Waaijenborg S., Crapo J. D., Bowler R. P., Akkerman J. N., Slot J. W. Colocalization of eNOS and the catalytic subunit of PKA in endothelial cell junctions: a clue for regulated NO production. Journal of Histochemistry and Cytochemistry 2004; 52: 1277–1285, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hu H. J., Kathi S. G., Robert W. G., IV. ERK integrates PKA and PKC signaling in superficial dorsal horn neurons I. Modulation of A-type K+ currents. Journal of Neurophysiology 2003; 90: 1671–1679, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ignarro L. J., Bryns R. E., Buga G. M., Wood K. S., Chaudhari G. Pharmacological evidence that endothelium-derived relaxing factor is NO: Use of pyrogallol and superoxide dismutase to study endothelium dependent and NO-elicited vascular smooth muscle relaxation. Journal Pharmacology and Experimental Therapeutics 1988; 244: 181–188, [CSA]
   PubMed Web of Science ®Google Scholar
• Irie K., Fujii E., Ishida H., Wada K., Suganuma T., Nishikori T., Yoshioka T., Muraki T. Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide induced microvascular permeability change in mouse skin. British Journal of Pharmacology 2001; 133: 237–242, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kamp T. J., Hell J. W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circulation Research 2000; 87: 1095–1102, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kawasaki H., Springett G. M., Mochizuki N., Toki S., Nakaya M., Matsuda M., Housman D. E., Graybiel A. M. A family of cAMP-binding proteins that directly activate Rap1. Science 1998; 282: 2275–2279, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kobayashi N., Mita S., Yoshida K., Honda T., Kobayashi T., Hara K., Nakano S., Tsubokou Y., Matsuoka H. Celiprolol activates eNOS through the PI3K-Akt pathway and inhibits VCAM-1 Via NF-kappaB induced by oxidative stress. Hypertension 2003; 42: 1004–1013, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kohn A. D., Summer S. A., Birnbaum M. J., Roth R. A. Expression of constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocystes stimulates glucose uptake and glucose transporter 4 translocation. Journal of Biological Chemistry 1996; 271: 31372–31378, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kung C. F., Moreau P., Takase H. L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Hypertension 1994; 26: 744–750, [CSA]
   Web of Science ®Google Scholar
• Laufs U., Liao J. K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. Journal of Biological Chemistry 1998; 273: 24266–24271, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Leemhuis J., Boutillier S., Schmidt G., Meyer D. K. The protein kinase A inhibitor H89 acts on cell morphology by inhibiting Rho-kinase. Journal of Pharmacology and Experimental Therapeutics 2002; 300: 1000–1007, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ma F. A., Liu L. Y., Xiong X. M. Protective effects of lovastatin on vascular endothelium injured by low density lipoprotein. Acta Pharmacologica Sinica 2003; 24: 1027–1032, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Marx S. O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A. R., Kass R. S. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002; 295: 496–499, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Meyer R. B., Jr., Miller J. P. Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymatic activity. Life Science 1974; 14: 1019–1040, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ming X. F., Viswambharan H., Barandier C., Ruffieux J., Kaibuchi K., Rusconi S., Yang Z. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Molecular and Cellular Biology 2002; 22: 8467–8477, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Mitra S., Singh M. Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta. Molecular and Cellular Biochemistry 1998; 183: 63–67, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pettipher E. R., Labasi J. M., Salter E. D., Stam E. J., Chen J. B., Griffiths R. J. Regulation of tumor necrotic factor production by adrenal hormones in vivo: Insights into the anti-inflammatory activity of rolipram. British Journal of Pharmacology 1996; 17: 1530–1534, [CSA]
   Google Scholar
• Pieper G. M., Langenstroer P., Siebeneich W. Diabetic induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovascular Research 1997; 37: 145–156, [CROSSREF], [CSA]
   Google Scholar
• Potente M., Urbich C., Sasaki K. I., Hofmann W. K., Heeschen C., Aicher A., Kollipara R., DePinho R. A., Zeiher A. M., Dimmeler S. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. Journal of Clinical Investigation 2005; 115: 2382–2392, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Quia J., Huang F., Lum H. PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. American Journal of Physiology 2002; 284: 972–980, [CSA]
   Google Scholar
• Sastry K. V.H., Moudgal R. P., Mohan J., Tyagi J. S., Rao G. S. Spectophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Analytical Biochemisytry 2002; 306: 79–82, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Schiller N. K., Timothy A. M., Chen I. L., Rice R. C., Akers D. L., Kadowitz P. J., McNamaran D. B. Endothelial cell regrowth and morphology after balloon catheter injury of alloxan-induced diabetic rabbits. American Journal of Physiology 1999; 277: 240–248, [CSA]
   Google Scholar
• Stitt T. N., Drujan D., Clarke B. A., Panaro F., Timofeyva Y., Kline W. O., Gonzalez M., Yancopoulos G. D., Glass D. J. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Molecular Cell 2004; 14: 395–403, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sugawara T., Fujimura M., Noshita N., Kim G. W., Saito A., Hayashi T., Narasimhan P., Maier C. M., Chan P. H. Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRX. 2004; 1: 17–25, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Sullivan G. W., Rieger J. M., Scheld W. M., Macdonald T. L., Linden J. Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A2A receptor agonists. British Journal of Pharmacology 2001; 132: 1017–1026, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Teixeira M. M., Gristwood R. W., Cooper N., Hellewell P. G. Phosphodiesterase 4 inhibitors: anti-inflammatory drugs of the future?. Trends in Pharmacological Sciences 1997; 18: 164–172, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Toba H., Gomyo E., Miki S., Shimizu T., Yoshimura A., Inoue R., Sawai N., Tsukamoto R., Asayama J., Kobara M., Nakata T. Hyperinsulinaemia increases the gene expression of endothelial nitric oxide synthase and the phosphatidylinositol 3-kinase/akt pathway in rat aorta. Clininical and Experimental Pharmacology and Physiology 2006; 33: 440–447, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ungvari Z., Paeher P., Rischak K., Szollar L., Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocystenemia. Arteriosclerosis, Thrombosis, Vascular Biology 1999; 19: 1899–1904, [CSA]
   PubMed Web of Science ®Google Scholar
• Ungvari Z., Sarkadi-Nagy E., Bagi Z., Szollar L., Koller A. Simultaneously increased TXA2 activity in isolated arterioles and platelets of rats with hyperhomocysteinemia. Arteriosclerosis, Thrombosis, Vascular Biology 2000; 20: 1203–1208, [CSA]
   PubMed Web of Science ®Google Scholar
• van Heerebeek L., Meischl C., Stooker W., Meijer C. J.L.M., Niessen H. W.M., Ross D. NADPH oxidase(s): New source(s) of reactive oxygen species in the vascular system?. Journal of Clinical Pathology 2002; 55: 561–568, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Waly M., Olteanu H., Banerjee R., Choi S.-W., Mason J. B., Parker B. S., Sukumar S., Shim S., Sharma A., Benzecry J. M., Power-Charnitsky V.-A., Deth R. C. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: A target for neuro developemental toxins and thimerosal. Molecular Psychiatry 2004; 51: 1–13, [CSA]
   Google Scholar
• Wagner A. H., Schroeter M. R., Hecker M. 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB Journal 2001; 15: 2121–2130, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wang H. D., Pagano P. J., Du Y., Cayatte A. J., Quinn M. T., Brecher P., Cohen R. A. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circulation Research 1998; 82: 810–818, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wang Y., Ahmad N., Kudo M., Ashraf M. Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning. American Journal of Physiology 2004; 287: 1125–1131, [CROSSREF], [CSA]
   Google Scholar
• Wolfrum S., Jensen K. S., Liao J. K. Endothelium-dependent effects of statins. Arteriosclerosis, Thrombosis, Vascular Biology 2003; 23: 729–736, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Zalba G., Beaumont F. J., San Jose G., Fortuño A., Fortuño M. A., Etayo J. C., Díez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055–1061, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar